HSP 90β Antibodies

Santa Cruz Biotechnology offers a broad range of HSP 90β monoclonal antibodies for research applications. HSP 90β monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HSP 90β plays a fundamental role in protein folding and stabilization, particularly for proteins involved in cell signaling and stress responses. The molecular chaperone HSP 90β maintains cellular homeostasis through its extensive network of interactions with client proteins. Research has shown that HSP 90β dysfunction is associated with various pathological conditions, including cancer and neurodegenerative disorders. Understanding HSP 90β behavior and interactions can reveal new therapeutic approaches and enhance knowledge of disease mechanisms. Investigating HSP 90β expression patterns and regulatory mechanisms provides insights into cellular stress responses and protein quality control systems. Current research focuses on exploring HSP 90β's role in cancer development, progression, and treatment resistance. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of HSP 90β and its impact on human health and disease.